Monthly Archives: June 2012

FDA Feels Pinch of House Funding Cuts

By Amy Ritter. The House Appropriations Committee released the fiscal year 2013 Agriculture Appropriations bill, which, sets proposed spending levels for FDA as well as for other programs. The bill calls for nearly $ 2.5 billion in discretionary funding, a cut of $16.3 million, or 0.7%, below last year’s level. Total proposed funding for the […]
Posted in Guest Blog, Regulatory | Tagged , , | Leave a comment

Drug Innovation: Alive and Well at ASCO!

By John Otrompke. This year’s annual meeting of the American Society of Clinical Oncology (ASCO), which ended on Tuesday, provided many examples of emerging therapies that offer new hope to even those patients with metastatic disease. Improved results in progression-free survival in clinical trials suggest that many forms of cancer may soon take on a […]
Posted in Events, Guest Blog, R&D | Tagged , , | 1 Comment

FDA User Fee Legislation Heads Toward Finish Line

Legislation to reauthorize Food and Drug Administration user fee programs sailed through the House and Senate last month, setting the stage for leading legislators to resolve their differences and agree on a compromise measure. Much of the work will be tackled by Committee staffers who have been laboring over the legislative details for months. The […]
Posted in Agency Insight, FDA, Regulatory | Tagged , , , | Leave a comment
  • Categories

  • Meta